# Candin Safety & Efficacy Study for the Treatment of Warts

> **NCT01757392** · PHASE2 · COMPLETED · sponsor: **Nielsen BioSciences, Inc.** · enrollment: 39 (actual)

## Conditions studied

- Warts
- Human Papilloma Virus

## Interventions

- **BIOLOGICAL:** Candida albicans Skin Test Antigen

## Key facts

- **NCT ID:** NCT01757392
- **Lead sponsor:** Nielsen BioSciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757392, "Candin Safety & Efficacy Study for the Treatment of Warts". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01757392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*